PRESS RELEASE published on 05/23/2024 at 06:45, 1 year 11 months ago Galenica on track with sales growth Galenica Group reports 4.8% sales growth in the first four months of 2024, driven by positive pharmaceutical market development. Outlook for 2024 confirmed with sales growth between 3% and 5% Sales Growth Outlook 2024 Galenica Group Pharmaceutical Market
BRIEF published on 04/16/2024 at 18:10, 2 years ago Galenica Successfully Issues CHF 100 Million Bond Corporate Finance SIX Swiss Exchange Bond Issue Financial Stability Galenica AG
PRESS RELEASE published on 04/16/2024 at 18:05, 2 years ago Galenica successfully places a bond of over CHF 100 million Galenica successfully places a CHF 100 million fixed rate bond with a 7-year term and 1.65% annual coupon. The proceeds will be used for general corporate purposes, securing long-term financing Bond Long-term Financing Galenica AG CHF 100 Million Fixed Rate
BRIEF published on 04/10/2024 at 17:34, 2 years ago Shareholders of Galenica AG unanimously approve at the 7th Ordinary General Meeting Board Of Directors Dividend Annual Accounts General Assembly Galenica SA
PRESS RELEASE published on 04/10/2024 at 17:29, 2 years ago 7th Annual General Meeting: Shareholders approve all proposals Galenica Ltd.'s 7th Annual General Meeting sees approval of all proposals, including dividend of CHF 2.20 per share and re-election of Board of Directors members Board Of Directors Annual General Meeting Dividend Approval Galenica Ltd.
BRIEF published on 03/12/2024 at 06:50, 2 years 1 month ago Galenica announces sustained growth in 2023 and optimistic forecasts for 2024 Financial Results Sustainable Development Online Pharmacy Galenica Growth 2024
PRESS RELEASE published on 03/12/2024 at 06:45, 2 years 1 month ago Galenica continues to grow in the 2023 financial year Galenica Group achieves 4.4% sales growth in 2023, proposing stable dividend. Expects 3-5% sales growth in 2024, increased adjusted EBIT by 8-11% 2024 Outlook Sales Growth Dividend Proposal Galenica Group Adjusted EBIT Increase
Published on 05/07/2026 at 05:40, 2 hours 56 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 6 hours 36 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 9 hours 6 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours 31 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 9 hours 36 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 08:24, 12 minutes ago Genel Energy PLC: Trading and operations update Q1 2026
Published on 05/07/2026 at 08:05, 31 minutes ago Hyundai Mobis Develops Power Electric Systems Ready to All EV Models
Published on 05/07/2026 at 08:05, 31 minutes ago Nota AI Signs AI Optimization Technology Supply and Strategic Partnership Agreement with Mobilint Accelerating Commercialization of On-Device AI on Domestic NPU Infrastructure
Published on 05/07/2026 at 08:00, 36 minutes ago Financial results Q1 2026 – Strong, profitable growth
Published on 05/07/2026 at 08:00, 36 minutes ago AIXTRON supplied Planetary GaN MOCVD Systems to Renesas for High-Volume Manufacturing Expansion
Published on 05/06/2026 at 18:00, 14 hours 36 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 14 hours 36 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 17:45, 14 hours 51 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
Published on 05/06/2026 at 17:45, 14 hours 51 minutes ago Declaration of voting rights at the end of April 2026
